Alirocumab gains indication to reduce cardiovascular risks
“These are substantial, clinically relevant improvements in clinical outcomes for patients with acute ischemic stroke."
Latest News
May 22, 2019
FDA panel to reassess the fate of paclitaxel-coated PAD devices
May 22, 2019
Vascular Specialist
May 17, 2019
Medicare withdraws plans to exclude drugs from Part D protected classes
May 17, 2019
Vascular Specialist
News from the SVS
May 22, 2019
Interested in starting a vascular surgery training program?
May 22, 2019
Vascular Specialist
Lifestyle
February 28, 2019
Cancer-battling breath, Zombie Bambi, and hops as health food
February 28, 2019
Vascular Specialist
February 20, 2019
Commentary: Physician burnout: It’s good to complain
February 20, 2019
Vascular Specialist
February 6, 2019
Michigan Medicine launches effort to make wellness a cultural norm
February 6, 2019
Vascular Specialist
Diabetes
May 6, 2019
Fournier gangrene cases surge in patients using SGLT2 inhibitors
May 6, 2019
Vascular Specialist
April 9, 2019
Dapagliflozin’s cardiovascular benefits bloom in T2D with prior MI
April 9, 2019
Vascular Specialist
April 8, 2019
CV disease and mortality risk higher with younger age of type 2 diabetes diagnosis
April 8, 2019
Vascular Specialist
April 2, 2019
Addressing insulin price spikes will require supply chain reform
April 2, 2019
Vascular Specialist
Practice Management
May 9, 2019
CBO predicts more Medicare spending with drug rebate proposal
May 9, 2019
Vascular Specialist
April 24, 2019
Report: Part B funds stable, hospital trust running out
April 24, 2019
Vascular Specialist
Aneurysms
May 14, 2019
Respiratory effects may account for worse survival in women undergoing DTA and TAAA repair
May 14, 2019
Vascular Specialist
March 13, 2019
Injectable nimodipine does not improve outcomes of subarachnoid hemorrhage
March 13, 2019
Vascular Specialist
February 19, 2019
Possible mechanism for fluoroquinolone-induced aortopathy uncovered
February 19, 2019
Vascular Specialist
PAD and Claudication
May 22, 2019
FDA panel to reassess the fate of paclitaxel-coated PAD devices
May 22, 2019
Vascular Specialist
April 24, 2019
New vascular 0 + 5 training programs yield fewer PAD cases
April 24, 2019
Vascular Specialist
Venous Diseases
January 14, 2019
ATTRACT trial shouldn’t detract from pharmacomechanical thrombolysis
January 14, 2019
Vascular Specialist
December 11, 2018
IgA vasculitis increases risks for hypertension, chronic kidney disease
December 11, 2018
Vascular Specialist
December 5, 2018
Large cohort study IDs prognostic factors in thromboangiitis obliterans
December 5, 2018
Vascular Specialist
November 19, 2018
Leg ulceration guidelines expected to soon include endovascular ablation
November 19, 2018
Vascular Specialist
Carotid Disease and Stroke
April 27, 2019
Alirocumab gains indication to reduce cardiovascular risks
April 27, 2019
Vascular Specialist
December 7, 2018
In Medicare population, carotid revascularization has declined
December 7, 2018
Vascular Specialist
December 7, 2018
Redo carotid endarterectomy is more risky than previously estimated
December 7, 2018
Vascular Specialist